Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Oil benchmarks jumped after a new round of U.S.-Iran strikes raised supply concerns and threatened to derail fragile ...
Insider moves can reveal a lot about a company's near-term strategy, but they rarely tell the whole story. This guide...
Quantum computing stocks moved lower in Monday trading as investors rotated into safer assets amid a broader tech mar...
A new frontier is waking up: autonomous AI agents powered by crypto. This morning minute reveals how on-chain incenti...
A major issuer boosted its quarterly dividend by 16%, even as shares retreat. This article breaks down what that sign...
Binance has filed a defamation lawsuit against the Wall Street Journal in SDNY after a February report alleged sancti...
ServiceNow's stock is down this year, but CEO Bill McDermott argues AI will accelerate growth, not derail it, outlini...
April 2026 data show a 2.4% year-over-year drop in new-home purchase applications, the first annual decline since lat...
Investors nudged Intel higher after AI infrastructure news signaled stronger demand for its CPU and accelerator lineu...
As AI features roll out and iPhone upgrades loom, investors face a nuanced picture: potential stock downside from wea...
Gen Z faces an AI-driven job market that keeps reshaping roles. This piece outlines adaptable skills and practical st...